Isoproterenol Hydrochloride (Isoproterenol Hydrochloride) Patent Expiration, LOE Window & CMS Spending

Isoproterenol Hydrochloride (Isoproterenol Hydrochloride) by 3M: FDA Approved Brand (No Listed Patent), 0 AB generics, $0 2024 CMS Part D & Medicaid spend, and $1,990 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated Sponsor3M
FDA Application & PathwayN010375 (NDA)
Exclusivity / Cliff HorizonFDA Approved Brand (No Listed Patent)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$0
2024 Medicare Part D Spend$0
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($1,990 intro WAC)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for 3M Health Care / Solventum across sibling Meru public-data platforms.